Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection

doi:10.3748/wjg.v23.i32.5969

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8407)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

404

WORD

178

HTML

3587

Figures (1-1)

213

Tables (1-3)

216

Sum=4598

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1277

Download

2532

Sum=3809

Aug 28, 2017 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Aug 28, 2017; 23(32): 5969-5976
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5969

Open in New Tab Full Size Figure Download Figure

Figure 1 Outcomes of hepatitis C virus RNA (A), alanine amino transferase levels (B) and estimated glomerular filtration rates (C) at different treatment time points in the six patients. EOT: End of therapy; ALT: Alanine aminotransferase; eGFR: Estimated glomerular filtration rate; HCV: Hepatitis C virus.

Citation: Xue Y, Zhang LX, Wang L, Li T, Qu YD, Liu F. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. World J Gastroenterol 2017; 23(32): 5969-5976
URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5969.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i32.5969